Quick Approval for COVID Vaccines a Concern, Rare Disease Patients Say

Quick Approval for COVID Vaccines a Concern, Rare Disease Patients Say

292592

Quick Approval for COVID Vaccines a Concern, Rare Disease Patients Say

More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less than willing to be vaccinated for COVID-19 if a vaccine was approved under emergency use authorization instead of the routine process, the EveryLife Foundation for Rare Disease reports. These findings highlight the need for a greater understanding of the U.S. Food and Drug Administration’s (FDA) emergency use authorization (EUA) process, as all current U.S. vaccines against this…

You must be logged in to read/download the full post.